Suppr超能文献

抗疟药物耐药性的反教条方法:用青蒿素联合疗法重新评估治疗失败。

Antidogmatic approaches to artemisinin resistance: reappraisal as treatment failure with artemisinin combination therapy.

机构信息

Centre for Infection and Immunity, Division of Clinical Sciences, St George's, University of London, Cranmer Terrace, London SW17 0RE, UK.

出版信息

Trends Parasitol. 2013 Jul;29(7):313-7. doi: 10.1016/j.pt.2013.04.001. Epub 2013 Apr 25.

Abstract

The definition of artemisinin resistance is becoming one of a prolonged parasite clearance phenotype, although this variable is a complex function of both host and parasite characteristics. We discuss some of the limitations of this definition of artemisinin resistance, particularly because of its potential global impact. This opinion article reviews the mechanisms underlying parasite clearance after artemisinin treatment and how these might relate to in vitro methods to assay for resistance. It revisits criteria for defining artemisinin resistance that are not currently being applied and suggests the term 'treatment failure of artemisinin combination therapy' (TFACT) as a more accurate description of most cases of 'artemisinin resistance'.

摘要

青蒿素耐药性的定义正在成为一种寄生虫清除表型的延长,尽管这种可变性是宿主和寄生虫特征的复杂函数。我们讨论了该青蒿素耐药性定义的一些局限性,特别是因为其潜在的全球影响。本文回顾了青蒿素治疗后寄生虫清除的机制,以及这些机制如何与体外检测耐药性的方法相关。它重新审视了目前未应用的青蒿素耐药性定义标准,并提出“青蒿素联合疗法治疗失败”(TFACT)一词作为大多数“青蒿素耐药性”病例的更准确描述。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验